What oral antibiotic should be prescribed for a male patient being discharged after hospitalization for a urinary tract infection caused by Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotic for Male Patient Discharged After Hospitalized UTI with Enterococcus faecalis

For a male patient being discharged after hospitalization for Enterococcus faecalis UTI, prescribe amoxicillin or ampicillin for 7-14 days (14 days if prostatitis cannot be excluded), provided the isolate is susceptible. 1

Treatment Selection Based on Susceptibility

First-Line: Aminopenicillins (If Susceptible)

  • Amoxicillin or ampicillin is the drug of choice for ampicillin-susceptible E. faecalis UTI 2
  • Aminopenicillins achieve extremely high urinary concentrations and may be effective even when isolates show in vitro resistance (MIC exceeding susceptibility breakpoint), particularly for lower UTI 3
  • E. faecalis demonstrates 88% susceptibility to nitrofurantoin and 72% susceptibility to ampicillin in contemporary data 4

Alternative Oral Options (If Ampicillin-Resistant or Intolerant)

Nitrofurantoin is the most reliable alternative:

  • 88% of enterococcal isolates remain susceptible 4
  • Has intrinsic activity against enterococci including resistant strains 5, 2
  • Appropriate for cystitis/lower UTI only (not for pyelonephritis or upper tract involvement)
  • Standard dosing: 100 mg twice daily

Fosfomycin (single 3g dose):

  • Has intrinsic activity against enterococci 5, 2
  • Limited to uncomplicated cystitis
  • Insufficient data for complicated UTI or pyelonephritis 6

Doxycycline:

  • Has intrinsic activity against enterococci 2
  • Only 11% susceptibility in some series, so requires susceptibility confirmation 4

Critical Pitfalls to Avoid

Do NOT Use Fluoroquinolones Empirically

  • Ciprofloxacin resistance in E. faecalis increases dramatically with age: 22% in young adults (18-29 years) to 37% in elderly (≥70 years) 7
  • Only use if susceptibility confirmed and local resistance <10% 1
  • Avoid if patient used fluoroquinolones in last 6 months 1

Do NOT Use TMP-SMX

  • Only 13% susceptibility to co-trimoxazole in enterococcal UTI 4
  • High resistance rates preclude empirical use 8

Duration of Therapy

The guideline-recommended duration is 7-14 days for complicated UTI in males 1:

  • Use 14 days when prostatitis cannot be excluded (which is common in male UTI)
  • May consider 7 days if patient has been afebrile ≥48 hours and no prostatic involvement 1
  • Beta-lactams for pyelonephritis: 7 days 6

Special Considerations for Males

Males with UTI are automatically classified as complicated UTI due to:

  • Higher likelihood of prostatic involvement
  • Greater anatomic complexity
  • E. faecalis is the 2nd most frequent pathogen (16%) in male outpatients with UTI 7
  • Recurrence rates are significantly higher with E. faecalis (26%) compared to E. coli (22%) 7
  • Recurrence increases with age: 12% in young adults to 28% in elderly 7

Clinical Algorithm

  1. Check culture susceptibilities immediately
  2. If ampicillin-susceptible: Prescribe amoxicillin 500 mg three times daily for 14 days
  3. If ampicillin-resistant but nitrofurantoin-susceptible AND lower UTI only: Prescribe nitrofurantoin 100 mg twice daily for 7 days
  4. If upper tract involvement or pyelonephritis with resistant organism: Consider linezolid or daptomycin (requires infectious disease consultation) 5, 2
  5. Remove any indwelling catheter if present 5

The key distinction is that aminopenicillins remain the gold standard when susceptible, and the male gender mandates longer treatment duration with high suspicion for prostatic involvement 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.